Literature DB >> 27854115

An investigation into respiratory tract viruses in children with acute lower respiratory tract infection or wheezing.

Demet Dabaniyasti1, Fahriye Eksi2, Özlem Keskin3, Mehmet Y Özkars3, Tekin Karsligil1, Iclal Balci1.   

Abstract

BACKGROUND: This study aimed to determine the frequencies of respiratory tract viruses in patient (acute lower respiratory tract infection [LRTI] or wheezing) and control (history of asthma without symptoms) groups.
METHODS: Using multiplex-polymerase chain reaction (PCR), respiratory tract viruses were investigated in the respiratory tract specimens from patient and control groups followed in the Pediatric Clinic.
RESULTS: The viruses detected in the patient and control groups (P=0.013) were as follows, respectively: rhinoviruses A, B, C (25.6% and 36.7%), influenza virus A (21.1% and 0.0%), parainfluenza virus type 1 (7.8% and 1.7%), parainfluenza virus type 4 (5.6% and 0.0%), adenoviruses A, B, C, D, E (4.4% and 1.7%), parainfluenza virus type 3 (4.4% and 1.7%), coronaviruses 229E and NL63 (4.4% and 1.7%), coronavirus OC43 (3.3% and 0.0%), respiratory syncytial virus A (3.3% and 0.0%), parainfluenza virus type 2 (2.2% and 0.0%), influenza virus B (2.2% and 0.0%), and respiratory syncytial virus B (1.1% and 1.7%). No bocavirus, metapneumovirus or enterovirus was found in any specimen. Statistically significant differences in the detection of influenza virus A (P=0.000), the total detection of parainfluenza viruses (P=0.008) and coinfection (P=0.004) were observed between the patient and control groups.
CONCLUSIONS: The advantage of our study compared with other studies is the inclusion of not only wheezing patients but also children with asthma without symptom. The higher detection of rhinoviruses both in patient and control groups give rise to thought that these viruses may be responsible for asthma exacerbations and may be related with long duration of virus shedding.

Entities:  

Year:  2016        PMID: 27854115     DOI: 10.23736/S0026-4946.16.04322-X

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  2 in total

1.  Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains.

Authors:  Shuai Xia; Wei Xu; Qian Wang; Cong Wang; Chen Hua; Weihua Li; Lu Lu; Shibo Jiang
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

2.  A Multicenter Study of Viral Aetiology of Community-Acquired Pneumonia in Hospitalized Children in Chinese Mainland.

Authors:  Yun Zhu; Baoping Xu; Changchong Li; Zhimin Chen; Ling Cao; Zhou Fu; Yunxiao Shang; Aihuan Chen; Li Deng; Yixiao Bao; Yun Sun; Limin Ning; Shuilian Yu; Fang Gu; Chunyan Liu; Ju Yin; Adong Shen; Zhengde Xie; Kunling Shen
Journal:  Virol Sin       Date:  2021-09-15       Impact factor: 4.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.